Cardiovascular Medication Use and Risk of Acute Exacerbation in Patients With Asthma-COPD Overlap (CVACO Study)

CONCLUSIONS: ARB, cardioselective beta-blocker, and DHP CCB therapies may lower the risk of AE in patients with ACO.PMID:35557496 | DOI:10.4168/aair.2022.14.3.314

Source: Allergy, Asthma and Immunology Research - May 13, 2022 Category: Allergy & Immunology Authors: Vincent Yi-Fong Su Szu-Wen Ko Yuh-Lih Chang Yueh-Ching Chou Hsin-Chen Lee Kuang-Yao Yang Kun-Ta Chou Chia-Chen Hsu Source Type: research